Your browser doesn't support javascript.
loading
Potential therapeutic effects of crocin.
Pourmousavi, Laleh; Asadi, Rasoul Hashemkandi; Zehsaz, Farzad; Jadidi, Roghayeh Pouzesh.
Affiliation
  • Pourmousavi L; Department of Sport Sciences, Tabriz Branch, Islamic Azad University, Tabriz, Iran.
  • Asadi RH; Department of Sport Sciences, Tabriz Branch, Islamic Azad University, Tabriz, Iran. hashemkandirasoul@gmail.com.
  • Zehsaz F; Department of Sport Sciences, Tabriz Branch, Islamic Azad University, Tabriz, Iran.
  • Jadidi RP; Department of Sport Sciences, Tabriz Branch, Islamic Azad University, Tabriz, Iran.
Article in En | MEDLINE | ID: mdl-38758225
ABSTRACT
Crocin, a natural bioactive compound derived from saffron (Crocus sativus) and other Crocus genera, has gained significant attention recently due to its potential therapeutic properties. The multifaceted nature of crocin's biological effects has piqued the interest of researchers and health enthusiasts, prompting further investigations into its mechanisms of action and therapeutic applications. This review article comprehensively explores the emerging evidence supporting crocin's role as a promising ally in protecting against metabolic disorders. The review covers the molecular mechanisms underlying crocin's beneficial effects and highlights its potential applications in preventing and treating diverse pathological conditions. Understanding the mechanisms through which crocin exerts its protective effects could advance scientific knowledge and offer potential avenues for developing novel therapeutic interventions. As we uncover the potential of crocin as a valuable ally in the fight against disorders, it becomes evident that nature's palette holds remarkable solutions for enhancing our health.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Naunyn Schmiedebergs Arch Pharmacol Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Naunyn Schmiedebergs Arch Pharmacol Year: 2024 Document type: Article